Skip to main content
Ethiopian Journal of Health Sciences logoLink to Ethiopian Journal of Health Sciences
. 2017 Sep;27(5):447–458. doi: 10.4314/ejhs.v27i5.2

The Effect of Psychosocial Factors and Patients' Perception of Tuberculosis Treatment Non-Adherence in Addis Ababa, Ethiopia

Habteyes Hailu Tola 1,2,, Gholamreza Garmaroudi 1, Davoud Shojaeizadeh 1, Azar Tol 1, Mir Saeed Yekaninejad 3, Luche Tadesse Ejeta 1, Abebaw Kebede 2, Desta Kassa 2
PMCID: PMC5615005  PMID: 29217949

Abstract

Background

Although there are several studies reported on factors affecting tuberculosis (TB) treatment non-adherence, there is information gap on psychosocial and patients' perceptions aspects. Therefore, this study was aimed to investigate the effect of psychosocial factors and patients' perceptions on TB treatment non-adherence in Ethiopia.

Methods

A cross sectional study was conducted in Addis Ababa from May to December, 2014. Thirty one health facilities were randomly selected and 698 TB patients, who had been on treatment, were enrolled consecutively using patient registration number. Structured questionnaire was used to collect data on demographics, knowledge, psychological distress, alcohol use, tobacco smoking and six HBM domains. Treatment adherence level was the main outcome variable, and it measured using visual analog scale. Statistical Package for Social Sciences version 20 was used for data analysis.

Results

Non-adherence level within last one month prior to the study was 19.5%. After controlling for all potential confounding variables, Antiretroviral Therapy (ART) status (Adjusted Odds Ratio (AOR) = 1.79, 95% Confidence interval (CI) (1.09 –2.95)), alcohol use (AOR = 2.11, 95% CI (1.33–3.37)), economic status (AOR = 0.53, 95% CI (0.33–0.82)), perceived barriers (AOR = 1.21, 95% CI (1.10–1.47)) and psychological distress (AOR = 1.83, 95% CI (1.47–2.29)) were independently associated with TB treatment non-adherence.

Conclusion

ART status, economic status, alcohol use, perceived barrier and psychological distress are the major areas that need to be targeted with health promotion intervention to enhance TB treatment adherence.

Keywords: Treatment Non-adherence, Determinants of treatment non-adherence, Health Belief Model, Tuberculosis

Introduction

Non-adherence to long term treatment is one of the major problems, which leads to poor treatment outcome due to its high risk of treatment failure and long term disease transmission (1,2). For instance, if we take the effect of drug resistance, the emergence of drug-resistance microbes is posing challenges to prevention and control programs of Tuberculosis (TB) (24). TB treatment non-adherence can also results in the occurrence of Multidrug Resistance, Extensively Drug Resistant TB (MDR-TB and XDR-TB) bacilli (3). According to WHO report, 3.6% and 20.2% of MDR-TB cases were registered among new and previously treated cases respectively in 2013 (5).

Apart from treatment failure and the occurrence of MDR-TB, treatment non-adherence has several socioeconomic impacts (68). For example, it can increase duration of treatment (6) and hospital bed occupancy rate (68), economic depletion and dependency (8), and induction of mental illness (7).

Treatment adherence is a complex phenomenon that is influenced by a wide range of interacting factors (7,9). Depression and anxiety, individual negative emotional status (10,11) and fear of stigma (12), general disease and its treatment knowledge (1217), patients' perception of the disease and its treatment (1820), lack of social support, and economic hardships are associated with TB treatment non-adherence (12,1517,21). Moreover, poorly oriented health services, poor medication distribution, poor communication and others are factors related to health care workers and the health system itself in respect to TB treatment adherence (16,17,22,23). On the other hand, studies show that alcohol consumption and tobacco smoking history (16,17,2426) and patients' HIV and Antiretroviral (ART) status are associated with TB treatment non-adherence (21,27).

Although previous studies reported several determinants of TB treatment non-adherence, few of them assessed the effect of psychosocial factors and individual patient's perception on TB treatment non-adherence. Moreover, though it is recommended to use social and behavioural science theoretical models to generate strong evidence on health promotion including treatment adherence (9,28,29) few studies have so far applied theoretical models to assess determinant factors of TB treatment non-adherence.

In Ethiopia, few studies have been conducted to assess determinant factors of TB treatment non-adherence, and based on these studies, the proportion of non-adherence rages from 10% to 21% (13,14,27). Apart from scarcity of information in Ethiopia, there is no study conducted based on theoretical models to determine psychosocial factors and individual patient's perception that influence TB treatment non-adherence. In addition, although previous studies conducted in Ethiopia reported numerous determinants of TB treatment non-adherence, none of them reported the effect of psychosocial factors and individual patient's perception based on theoretical model (13,14,22,27). Therefore, this study was aimed to determine the effect of psychosocial and individual patient's perception on TB treatment non-adherence based on Health Belief Model (HBM) in Ethiopian.

HBM is the most widely used and important model to understand and explain health behaviors including treatment adherence as a healthy practice (30,31). However, it is being criticized for focusing on individual characteristics and cognitive factors, giving less attention to social influences and emotional components of behavior. This theoretical model consists of six domains in its recent version (29). These are perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cue to action and perceived self-efficacy (29). According to HBM concept, TB patients with a given sociodemographic characteristics and mental health status are likely to follow their medicinal regimen correctly under a specific five sets of conditions (31,32). These are:

  1. TB patients must have some minimal knowledge on their illness and motivation to be free of TB;

  2. TB patients must perceive themselves as susceptible to TB and must also believe that TB disease and consequences of non-adherence can cause serious medical and health problems;

  3. TB patients must also be influenced by the effectiveness of TB treatment, which could result in the possibility to obtain control over the tangible and psychological barriers at acceptable level;

  4. The presence of an internal or external stimulus, referred as “cue to action,” is a trigger of adherence behavior of TB patients'; and

  5. TB patients' trust in self-ability to strictly follow the treatment till the final dose. Based on the HBM theoretical concepts mentioned above, this study applied the model to determine the effect of psychosocial factors and individual patient's perception on TB treatment adherence.

Methods

Study design and setting: A cross sectional study was conducted to determine the effect of psychosocial factors and individual patient's perception on TB treatment non-adherence in Addis Ababa from May to December, 2014. Addis Ababa consists of 10 sub-cities with an estimated total population 2,975,608 (33). In addition, it consists of 53 health centers and 10 public hospitals (34). All diagnosed TB patients are treated under Directly Observed Treatment (DOT) strategy (35).

Study population and sampling: The study population was all types of TB patients who were on first line and MDR-TB treatment regimens under Directly Observed Treatment Short course (DOTS) strategy in randomly selected 30 Health Centers (HCs) and one purposively selected TB specialized hospital in Addis Ababa. Thirty HCs were selected using simple random sampling technique from 53 HCs, located in the city. The number of HCs (clusters) selected was set at 30 based on WHO recommendation regarding minimum number of survey clusters (36). From selected study sites, 698 TB patients, who had been on treatment for one month and above, older than 17 years and living in Addis Ababa for more than six months were enrolled consecutively from TB registration book using patients' identification numbers. However, severely sick and mentally incapable patients were excluded. Consecutive enrollment of participants from registration book was used to achieve the maximum sample size and to avoid selection bias.

Data collection instrument and procedure: A structured questionnaire was used to collect sociodemographic data. Economic status was assessed with 10 structured questions which ask ownership position of basic assets. The response of each question was recorded by yes = 1 and no = 0. To estimate the total score of economic status, one dimension Categorical Principal Component Analysis (CPCA) technique was used. Thirty eight structured items were employed to collect TB disease and its treatment related knowledge. The responses to each knowledge question were recorded on three level Likert's scale such as “correct”, “incorrect” and “don't know”. One point was given for each correct answer (correct response score = 1) and zero for incorrect and don't know responses (incorrect and don't know responses score = 0) (Table 1). The total knowledge score was calculated using total sum method. In addition, a total of 76 structured items were designed based on literature review and the concept of HMB to collect information on six HBM domains. The degree with which each of these items expressed was recorded using a five-point Likert's scale ranging from “strongly disagree” with lower score (1) to “strongly agree” with higher score (5) (Table 1). Total perception score of each HBM domain was estimated by CPCA. To show frequency distribution of non-adherence level with respect to knowledge and perception levels, total knowledge score and total HBM domains scores were dichotomized using median score of each variable as a cut-off point. However, in the logistic regression modeling, continuous scores of knowledge and HBM domains were used (Table 4). To assess the presence of psychological distress symptoms characterized by depression and anxiety in the last one month, Kessler-10 items (K-10) scale was used (37,38). The frequency with which each of these items experienced was recorded using a five-point Likert's scale ranging from “none of the time” with lower score to “all the time” with higher score (Table 1). The total psychological distress score was estimated by CPCA. This scale has been largely used to assess common mental disorders (CMDs) among TB patients, and has been validated in several settings (39) including in Ethiopia (40). WHO Alcohol Use Disorder Identification Test (AUDIT) 10 items was used to assess alcohol use history (41), while tobacco smoking history was collected using Australian Smoking Assessment Check list (42). Information on TB patients' HIV and ART status was collected from participant self-report and rechecked from TB registration book. The questionnaire was validated prior to use for main study data collection by test and retest pilot study at selected study sites. Internal consistency of HBM domains and other variables were assessed using Cronbach's α analysis and the results were in acceptable range (0.70) (Table 1). Adherence level of patients was assessed by participant self report with Visual Analogues Scale (VAS) after carful explanation. In addition, participants who interrupted treatment due to medication adverse effect and lost to follow-up were interviewed through home visit after agreement was obtained through telephone call. VAS was scaled from 0% to 100% and re-coded to dichotomous variable (adherent or non-adherent) using 90% cut-off point based on WHO adherence definition (4). WHO defines TB treatment non-adherent as “patients who did not attend a health facility at the scheduled visit and those who did not take regular medication above 90% of prescribed doses” (4). Therefore, in this study, non-adherent patients were: (1) those who scored their adherence level less than 90%, (2) those who interrupted their treatment due to medication adverse effects, and (3) those who were lost to follow-up.

Table 1.

Response score mean standard deviation and Cronbach's alpha of knowledge, psychological distress and each HBM domain

Variable No. Items Scale Mean score Standard deviation Cronbach's alpha
Knowledge Score 38 0–1 30.5 4.7 0.85
Perceived Susceptibility 9 1–5 28.2 6.6 0.78
Perceived Severity 9 1–5 36.9 5.0 0.76
Perceived Benefit 8 1–5 32.8 4.1 0.80
Perceived Barrier 31 1–5 65.5 16.6 0.75
Cue to action 7 1–5 31.7 5.3 0.77
Perceived Self-efficacy 12 1–5 51.5 5.6 0.82
Psychological distress 10 1–5 18.71 7.83 0.93
Alcohol use disorder 10 0–4 3.5 2.7 0.90

Table 4.

Predictors of TB treatment non-adherence

Characteristics Crud OR (95% CI) P-Value Adjusted OR (95% CI) P-Value
Gender Female 1.00
Male 0.83(0.57–1.21) 0.335
Marital Status Married 1.00 0.476
Unmarried 1.17(0.78–1.76)
Diploma & 1.00
Educational Status Above
High School
& Less
2.17(1.06–4.46) 0.053 2.1(0.99–4.52) 0.053
Current Smoking History Non-smoking 1.00
Smoker 1.29(0.69–2.42) 0.495
TB Treatment History New 1.00
Previously 1.50(1.00–2.27) 0.059 1.43(0.90–2.25) 0.128
Treated
TB Type EPTB 1.00
PTB 1.43(0.93–2.18) 0.267
HIV Sero-status None 1.00
Reactive
Reactive 0.86(0.55–1.35) 0.561
ART* Status Not on ART 1.00
On ART 1.73(1.09–2.73) 0.022 1.79(1.09–2.95) 0.023
AUDR No Risk 1.00
There is Risk 2.06(1.29–3.29) 0.001 2.11(1.33–3.37) 0.002
Age (in year) 1.00(0.99–1.02) 0.843
Economic Status 0.52(0.35–0.76) 0.001 0.53(0.33–0. 82) 0.004
Psychological Distress 1.65(1.45–2.00) <0.001 1.83(1.47–2.29) <0.001
Knowledge 0.99(0.96–1.03) 0.763 0.98(0.96–1.05) 0.841
Perceived Susceptibility 0.81(0.67–1.00) 0.051 0.81(0.62–1.05) 0.106
Perceived Severity 0.80(0.68–0.95) 0.078 0.95(0.73–1.23) 0.678
Perceived Barrier 1. 35(1.16–1.57) <0.001 1.21(1.10–1.47) 0.014
Perceived Benefit 0.81(0.78–1.21) 0.059 0.89(0.69–1.15) 0.243
Cue to Action 0.82(0.70–0.97) 0.019 0.85(0.67– 1.10) 0.203
Perceived Self-efficacy 0.88(0.78–0.99) 0.034 0.98(0.77–1.17) 0.224
*

ART-Antiretroviral Therapy,

PTB-Pulmonary TB,

EPTB-Extra Pulmonary TB,

AUD-Alcohol Use

Data was collected by health professionals at each study site. Before data collection, a three days' training was offered to data collectors on how to administer the questionnaire. Data collectors were supervised during data collection on regular basis.

Data entry and analysis: Data was analyzed using Statistical Package for Social Science (SPSS) version 20. Proportions of non-adherence among participants' characteristics, knowledge score, six HBM domains scores and psychological distress score were determined to show the frequency distribution of treatment non-adherence. Before running multivariable logistic regression, bivariate analysis was conducted between each independent variable and non-adherence level. Variables with p-value less than 0.2 in bivariate analysis were included in multiple logistic regressions. However, although knowledge and the six HMB domains had p-value greater than 0.2, they were included in the final model because they were the main exposure variables in the study and the main constructs of HBM model.

Ethical approval: This study protocol was ethically approved by Tehran University of Medical Sciences and the Ethiopian Public Health Institute Research Ethics Board. Both oral and written informed consent was obtained from each study participant.

Results

Sociodemographic characteristics: A total of 698 all forms of TB [Pulmonary = 416(59.6%)), Extra pulmonary = 215(30.8%), MDR-TB = 67(9.6%)] patients on treatment for one and above months were included in the study (Table 2). The age range of participants was 18–90 years, and about 457(65.5%) participants were less than 35 years of age. More than half (55.9%) of the participants were elementary school and below in terms of educational attainment, and 53.4% were unemployed and daily laborers (Table 2). About 29.3% participants were migrants from rural areas to Addis Ababa and of these, 18.1% were daily laborers.

Table 2.

Study Participants' Characteristics (n = 698)

Variables Frequency 95% CI of %
Gender Female 297 42.6(38.9 – 46.3)
Male 401 57.4(53.8 – 61.1)
18–24 193 27.7(24.5 – 31.1)
Age Groups (in year) 25–34 264 37.8(34.3 – 41.5)
35–44 136 19.5(16.7 – 22.6)
45 & above 104 14.9(12.4 – 17.7)
Missing 1 0.1(0.0 – 0.9)
Elementary & less 390 55.9(52.2 – 59.5)
Educational Status High School Graduate 224 32.1(28.3 – 35.6)
Diploma & Above 84 12.0(9.8 – 14.7)
Marital Status Married 224 32.1(28.7 – 35.6)
Unmarried 474 67.9(64.4 – 71.3)
Employed 325 46.6(42.9 – 50.3)
Employment Status Unemployed 294 42.1(38.5 – 45.8)
Daily Laborer 79 11.3(9.2 – 13.9)
Current Smoking History Smoker 60 8.6(6.7 – 10.9)
None Smoker 638 91.4(89.1 – 93.3)
TB Treatment History New 527 75.5(72.2 – 78.5)
Previously Treated 171 24.5(21.5 – 27.8)
PTB 416 59.6(55.9 – 63.2)
TB type EPTB 215 30.8(27.5 – 34.3)
MDR-TB§ 67 9.6(7.6 – 12.0)
HIV Sero-status None Reactive 548 78.5(75.3 – 81.4)
Reactive 150 21.5(18.6 – 24.7)
ART* Status Not on ART 581 83.2(80.3 – 85.8)
On ART 117 16.8(14.2 – 19.7)
Alcohol Use Disorder Risk There is Risk 105 15.0(12.6 – 17.9)
No Risk 593 85.0(82.1 – 87.4)
Psychological Distress Symptom No Symptom 357 51.1(47.4 – 54.8)
There is Symptom 341 48.9(45.2 – 52.6)
*

ART-Antiretroviral Therapy,

PTB-Pulmonary TB,

EPTB-Extra Pulmonary TB,

§

MDR-TB-Multidrug Resistant TB

Table 3 depicts proportions of non-adherence with respect to study participants' characteristics. A total of 136(19.5%) participants were non-adherent. Of the total non-adherent participants, males were slightly more, 73(53.7), than females 63(46.3%). Participants in the age group of less than 35 years were more non-adherent, 91(66.9%), compared to other age groups. Similarly, large proportions of non-adherent participants were unmarried (70.6%), elementary school and below, (60.3%), at low socioeconomic status, (61.8%), newly started TB treatment, (70%), and pulmonary TB patients, (64.7%).

Table 3.

Participant characteristics distribution of TB treatment non-adherence

Characteristics Adherence

Adherent % (95% CI) Non-Adherent % (95% CI)
Gender Female 234 41.6(37.6 – 45.8) 63 46.3(38.2 – 54.7)
Male 328 58.4(54.2 – 62.4) 73 53.7(45.3 – 61.8)
18–24 160 28.5(24.9 – 32.3) 33 24.3(17.8 – 32.2)
Age Group 25–34 206 36.7(32.8 – 40.7) 58 42.6(34.7 – 51.1)
35–44 111 19.8(16.7 – 23.3) 25 18.4(12.7 – 25.8)
45 & Above 84 14.9(12.2 – 18.1) 20 14.7(9.7 – 21.7)
Marital Status Married 184 32.7(29.0 – 36.7) 40 29.4(22.4 – 37.6)
Unmarried 378 67.3(63.3 – 71.0) 96 70.6(62.4 – 77.6)
Employed 271 48.2(44.1 – 52.4) 54 39.7(31.9 – 48.1)
Employment Unemployed 229 40.7(36.8 – 44.9) 65 47.8(39.6 – 56.1)
Status Daily Laborer 62 11.0(8.7 – 13.9) 17 12.5(7.9 – 19.2)
Elementary & less 308 54.8(50.7 – 58.9) 82 60.3(51.9 – 68.1)
Educational High School 179 31.9(28.1 – 35.8) 45 33.1(25.7 – 41.4)
Status Diploma & above 75 13.3(10.8 – 16.4) 9 6.6(3.4 – 12.3)
Economic Status Low 233 41.5(37.5 – 45.6) 84 61.8(53.4 – 69.5)
Medium 146 26.0(22.5 – 29.8) 34 25.0(18.5 – 32.9)
High 183 32.6(28.8 – 36.6) 18 13.2(8.5 – 20.0)
Current Smoking Smoker 46 8.2(6.2 – 10.8) 14 10.3(6.1 – 16.7)
History None Smoker 516 91.8(89.2 – 93.8) 122 89.7(83.4 – 93.9)
TB Treatment New 433 77.0(73.4 – 80.3) 94 69.1(60.9 – 76.3)
History Previously Treated 129 23.0(19.7 – 26.6) 42 30.9(23.7 – 39.1)
PTB 328 58.4(54.2 – 62.4) 88 64.7(56.4 – 72.2)
TB type EPTB 181 32.2(28.3 – 36.2) 34 25.0(18.5 – 32.9)
MDR-TB§ 53 9.4(7.3 – 12.2) 14 10.3(6.1 – 16.6)
HIV Sero Status None Reactive 444 79.0(75.4 – 82.2) 104 76.5(68.6 – 82.9)
Reactive 118 21.0(17.8 – 24.6) 32 23.5(17.2 – 31.4)
ART Status* On ART 80 14.2(11.6 – 17.4) 32 23.5(17.2 – 31.4)
Not on ART 477 84.9(81.7 – 87.6) 104 76.5(68.4 – 82.9)
AUD No Risk 489 87.0(84.0 – 89.6) 104 76.5(68.4 – 82.9)
There is Risk 73 13.0(10.5 – 16.0) 32 23.5(17.2 – 31.4)
PDS** No Symptom 293 52.1(48.0 – 56.2) 64 47.1(38.9 – 55.4)
There is Symptom 269 47.9(43.8 – 52.0) 72 52.9(44.6 – 61.1)
*

ART-Antiretroviral Therapy,

PTB-Pulmonary TB,

EPTB-Extra Pulmonary TB,

§

MDR-TB-Multidrug Resistant TB,

AUD-Alcohol Use Disorder,

**

PDS-Psychological distress symptom

Knowledge and perception regarding TB disease and its treatment: The mean knowledge score of the participants was 30.5 (±4.7), and 59.0% of them were scored more than mean score of knowledge. Among non-adherent participants, 92(67.7%) scored less than the mean knowledge score. The mean perceived susceptibility and perceived severity scores were 28.2 (SD = 6.6) and 36.9 (SD = 5.0) respectively. Similarly, the mean score of perceived barrier was 65.5 (SD = 16.6) and the mean score of perceived benefit was 32.8(SD = 4.1). Moreover, the mean score of cue to action and perceived self-efficacy were 31.7(SD = 5.3) and 51.5 (SD = 5.6) respectively (Table 3).

Alcohol use and tobacco smoking: The mean alcohol use disorder score on WHO 10 items AUDIT was 3.5(SD = 2.7). Using WHO AUDIT cut-off point (greater than 8 total score) 111(15.0%) of the participants fulfilled hazardous and harmful alcohol use as well as possible alcohol dependence. Out of the total non-adherence, (19.5%), 42(28%) of the participants had alcohol use disorder symptoms. More than 90% of the participants were non-smoker, and of the total (60) smokers, 14(23.3%) participants were non-adherent, while slightly lower (19.1%) were non-adherent from non-smokers.

Psychological distress: The mean score of psychological distress was 18.7(SD = 7.8) on K- 10 items. Slightly less than half (48.9%) of the participant met the criteria for psychological distress on cut-off point of 15 score. Of 136(19.5%) the total non-adherence, 76(27.4%) showed symptoms of psychological distress.

Bivariate analysis: On Bivariate analysis (Table 4), high school completion (Crude Odds Ratio (COR) = 2.17, 95% Confidence Interval (CI), (1.06–4.46)), being on ART (COR = 1.73, 95% CI (1.09–2.73)), availability of AUD (COR = 2.06, 95% CI (1.29–3.29)), high economic status (COR = 0.52, 95% CI (0.35–0.76)), perceived barriers (COR = 1.35, 95% CI (1.35–1.16)) and psychological distress (COR = 1.65, 95% CI (1.45–2.00) were significantly associated with TB treatment non-adherence.

Multivariate analysis: The final multivariable logistic regression model contains five independent variables (ART status, TB treatment history, educational status, economic status, knowledge level), and six HBM domains indicated a high goodness of fit with the data (χ2 =70.07, p<0.001), demonstrating that the model was able to differentiate between participants who were adherent and non-adherent. The final multivariable logistic regression analysis revealed that, being on ART (Adjusted Odds Ratio (AOR) = 1.79, 95% CI (1.09–2.95)), AUD (AOR = 2.11, 95% CI (1.33–3.37)), high economic status (AOR = 0.53, 95% CI (0.33–0. 82)), perceived barrier (AOR = 1.21, 95% CI (1.10–1.47)) and psychological distress (AOR = 1.83, 95% CI (1.47–2.29)) were independently associated with treatment non-adherence (Table 4).

Discussion

For successful treatment outcome, optimal treatment adherence is mandatory. According to WHO, to be adherent, patient should attend the scheduled visit and take regular medication above 90% of prescribed doses (4). However, evidences show that, a considerable number of TB patients are interrupting their treatment due to various and interrelated psychological (10,11), socio- economic (11,12,16,17,21,43), behavioral (1820), health care system (22) and health care workers related factors (13,14,23).

In this study, the proportion of treatment non-adherence was found to be higher than studies recently reported from Ethiopia (14,27). Multivariable logistic regression analysis revealed that ART status, alcohol use, economic status, perceived barrier and psychological distress were able to independently predict TB treatment non-adherence.

The overall non-adherence proportion of our study was nearly comparable with a previous study reported from Ethiopia (13). However, it was higher than other recently reported studies from the country (14,27). This difference on non-adherence level is most probably due to differences in adherence measurement techniques used and study population addressed. Study populations of both studies (14,27) were rural and urban mixed populations; however, our study population was urban dwellers. In addition, about 29.3% of the participants studied were immigrants from rural part of Addis Ababa before six months, and of these, 18.1% were daily laborers who were struggling to fulfill their daily living. These participants may easily enter into treatment interruption because of hard living situations and even they might have gone back to their original places abandoning the treatment to seek support from family as previous study reported (15). Moreover, a study conducted by Sendagire et al. (26) reported that urban movement and alcohol consumption had significant associations with loss to follow-up among urban population. Regarding non-adherence measurement technique, a study reported by Adane et al. (27) used pills counting technique and study reported by Kiros et al. (14) used VAS, but health care workers were used to estimate non-adherence level of patients. However, in our study, we used VAS and non-adherence level was estimated by individual patient themselves, being supported by health care workers. Hence, we assume that this non-adherence proportion differences occurred most probably due to these factors (non-adherence measurement techniques).

Previous studies reported from Ethiopia (12,13) demonstrated that being on dual treatment (on TB and HIV treatment) and pills burden were the most significant barriers of TB treatment adherence. This result was consistent with our findings, i.e. TB patients on dual treatment (anti TB and ART) were 1.82 times more non-adherent than those who were not on dual treatment.

Economic hardship is the highest determinant of treatment non-adherence. According to previous studies, TB patients who have financial limitation are more likely to be in devastating situation from lack of transportation cost and living costs which are important to regular treatment follow-up (12,16,17,21). Furthermore, poverty is one of the major barrier to healthy behavior practice like strictly following treatment, and it could easily put patients into risky behaviors such as tobacco smoking and alcohol misuse due to lack of enabling environment. Thus, being poor and practicing risky behaviors such as alcohol consumption and tobacco smoking would likely lead to poor health outcomes as the consequence of treatment non-adherence (21). Our study also revealed a similar result, and TB patients who were at high economic score were 31% times likely to be non-adherent than participants who were at low economic score.

Naidoo et al. (21) and Sendagire et al. (26) reported that AUD risk was strongly associated with TB treatment non-adherence. The results of these studies were in agreement with our finding, and TB patients who were at AUD on WHO AUDIT 10- items were 1.89 times likely to be non-adherent than those who were not at AUD. This may be due to the fact that TB patients who drink alcohol may miss their medication to drink alcohol with friends and may miss their treatment due to memory and decision impairment related to alcohol. Moreover, according to a study reported from Uganda (23), as most TB patients who dirk alcohol are residing in slam areas and tend to give wrong addresses, they would be easily lost to follow-up and could not be traced back after interrupting their treatment.

Perceived tangible (social, economic, health care system and health care worker factors) and individual belief about TB disease and its treatment barriers were associated with TB treatment non-adherence. This result was alongside with the study reported by Llongo (31), which showed the impact of a patient's incongruent belief on treatment adherence based on HBM. In addition, our finding was consistent with previous studies that showed the effect of tangible barriers on treatment adherence without applying HBM (1821).

According to a study reported by Prince et al. (44) and a systematic review reported by Pachi et al (10), the association between mental illness and other co-morbidities contributes to TB treatment non-adherence. These study findings were consistent with our finding in which TB patients who had psychological distress symptoms were 1.83 time more at risk of non-adherent than those who had no symptoms.

The study questionnaire was administered by health care worker at the TB clinic of the selected study areas. Thus, health care workers could have overestimated the adherence level of patients to demonstrate their work performance. This could be the main limitation of this study. On the other hand, TB patients themselves may not give their own exact perception particularly related to health care workers and health care facilities, as the questionnaire was administered by health care works themselves. This may lead to under reporting of tangible barriers that are related to health care workers behaviors and health care facilities' services.

Despite these limitations, we conclude that non-adherence level was 19.5% among TB patients on treatment. ART status, economic status, AUD, perceived barriers and psychological distress were significantly associated with TB treatment non-adherence. Thus, implementation of comprehensive interventions, focusing on poverty, AUD, perceived barriers to treatment and psychological counseling are important to enhance TB treatment adherence.

Acknowledgement

The authors acknowledge the contribution of KNCV/USAID TBCARE-I and Ethiopian Public Health Institute for funding this study. Also, the authors extend their gratitude to Tehran University of Medical Sciences-International Campus for awarding the diamond scholarship for first author.

References

  • 1.Hall RG, Leff RD, Gumbo T. Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29(12):1468–1481. doi: 10.1592/phco.29.12.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bastakoti S, Khanal S, Dahal B, Pun NT. Treatments: Focus on Pharmacy Practice in Nepal. JCDR. 2013;7(4):754–757. doi: 10.7860/JCDR/2013/4872.2905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hirpa S, Medhin G, Girma B, Melese M, Mekonen A, Suarez P. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa : a case control study. BMC Public Health. 2013;13(1):1. doi: 10.1186/1471-2458-13-782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.WHO, author. Adherence to long-term therapies: Evidence for action. Geneva, Switzeland: WHO Press; 2003. [Google Scholar]
  • 5.WHO, author. Global Tuberculosis Report, WHO report. Geneva, Switzerland: 2014. p. 8. [Google Scholar]
  • 6.Pettit AC, Cummins J, Kaltenbach LA, Sterling TR, Warkentin JV. Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis. Int J Tuberc Lung Dis. 2013;17(4):486–492. doi: 10.5588/ijtld.12.0133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Boogaard Jossy Van Den, Boeree Martin J, Kibiki Gibson S, Aarnoutse RE. The complexity of the adherence-response relationship in tuberculosis treatment : why are we still in the dark and how can we get out? TMIH. 2011;16(6):693–698. doi: 10.1111/j.1365-3156.2011.02755.x. [DOI] [PubMed] [Google Scholar]
  • 8.Payero MÁ, Castro NML De, Samartín MU, Vila AM, López CV, Piñeiro G. Medication non- adherence as a cause of hospital admissions. Farm Hosp. 2014;38(4):328–333. doi: 10.7399/fh.2014.38.4.7660. [DOI] [PubMed] [Google Scholar]
  • 9.Munro S, Lewin S, Smith H, Engel M, Atle F, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(Suppl 7):e238. doi: 10.1371/journal.pmed.0040238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients. Tube Res Treat. 2013;2013:37. doi: 10.1155/2013/489865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Lomakina OB, Kourbatova EV. Impact of socio-psychological factors on treatment adherence of TB patients in Russia. Tuberc. 2008;88(5):495–502. doi: 10.1016/j.tube.2008.03.004. [DOI] [PubMed] [Google Scholar]
  • 12.Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment : a qualitative study. BMC Public Health. 2010;10(1):651. doi: 10.1186/1471-2458-10-651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kebede A, Wabe TN. Medication Adherence and its Determinants among Patients on Concomitant Tuberculosis and Antiretroviral Therapy in South West Ethiopia. N Am J Med Sci. 2012;4(2):67–71. doi: 10.4103/1947-2714.93376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kiros YK, Teklu T, Desalegn F, Tesfay M, Klinkenberg E, Mulugeta A. Adherence to anti-tuberculosis treatment in Tigray, Northern Ethiopia. PHA. 2014;4(4):S31–S36. doi: 10.5588/pha.14.0054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sagbakken M, Frich JC, Bjune G. Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia : a qualitative study. BMC Public Health. 2008;11:1–11. doi: 10.1186/1471-2458-8-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya : A case control study. BMC Public Health. 2011;11(1):696. doi: 10.1186/1471-2458-11-696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Maruza M, Fp M, Albuquerque M, Coimbra I, Moura LV, Montarroyos UR, et al. Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil : a prospective cohort study. BMC Infect Dis. 2011;11(1):351. doi: 10.1186/1471-2334-11-351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(6):521–528. doi: 10.1097/MLR.0b013e318032937e. [DOI] [PubMed] [Google Scholar]
  • 19.Cramm JM, Finkenflügel HJM, Møller V, Nieboer AP. TB treatment initiation and adherence in a South African community influenced more by perceptions than by knowledge of tuberculosis. BMC Public Health. 2010;10:72. doi: 10.1186/1471-2458-10-72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding Patients' Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633. doi: 10.1371/journal.pone.0080633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Naidoo P, Peltzer K, Louw J, Matseke G, Mchunu G, Tutshana B. Predictors of tuberculosis ( TB ) and antiretroviral ( ARV ) medication non-adherence in public primary care patients in South Africa : a cross sectional study. BMC Public Health. 2013;13:396. doi: 10.1186/1471-2458-13-396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tadesse T, Demissie M, Berhane Y, Kebede Y, Abebe M. Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia : a qualitative study. BMC PublicHealth. 2013 doi: 10.1186/1471-2458-13-424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Elbireer S, Guwatudde D, Mudiope P, Nabbuye-sekandi J, Manabe YC. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Trop Medand Int Heal. 2011;16(8):981–987. doi: 10.1111/j.1365-3156.2011.02800.x. [DOI] [PubMed] [Google Scholar]
  • 24.Peltzer K, Louw J, Mchunu G, Naidoo P, Matseke G, Tutshana B. Hazardous and Harmful Alcohol Use and Associated Factors in Tuberculosis Public Primary Care Patients in South Africa. Int J Env Res Public Heal. 2012;9(9):3245–3257. doi: 10.3390/ijerph9093245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lavigne M, Rocher I, Steensma C, Brassard P. The impact of smoking on adherence to treatment for latent tuberculosis infection. BMC Public Health. 2006;6:66. doi: 10.1186/1471-2458-6-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sendagire I, Schim Van der Loeff M, Kambugu A, Konde-Lule J, Cobelens F. Urban Movement and Alcohol Intake Strongly Predict Defaulting from Tuberculosis Treatment: An Operational Study. PLoS One. 2012;7(5):e35908. doi: 10.1371/journal.pone.0035908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Adane AA, Alene KA, Koye DN, Zeleke BM. Non-adherence to anti-tuberculosis treatment and determinant factors among patients with tuberculosis in northwest Ethiopia. PLoS One. 8(11):e78791. doi: 10.1371/journal.pone.0078791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Glanz K, Bishop DB. The Role of Behavioral Science Theory in Development and Implementation of Public Health Interventions. Annu Rev Public Heal. 2010;13:399–418. doi: 10.1146/annurev.publhealth.012809.103604. [DOI] [PubMed] [Google Scholar]
  • 29.Glanz K, Rimer BK, Viswanath K. Health Behavior and Health Education: Theory, Research, and Practice. 4th ed. USA, San Francisco: Jossey-Bass; 2008. [Google Scholar]
  • 30.Poss J. The meaning of tuberculosis for Mexican immigrant farm workers in the United States. Soc Sci Med. 1998;47:95–202. doi: 10.1016/s0277-9536(98)00062-8. [DOI] [PubMed] [Google Scholar]
  • 31.Llongo I. Tuberculosis health belief gaps of tuberculosis and suspected tuberculosis cases in New York City. Int J Clin Heal Psychol. 2004;4(1):69–90. [Google Scholar]
  • 32.Barnhoon NF, Adriaanse H. In search of factors responsible for non-compliance among tuberculosis patients in Wardha district, India. Soc Sci Med. 1992;34:291–306. doi: 10.1016/0277-9536(92)90271-q. [DOI] [PubMed] [Google Scholar]
  • 33.Ethiopian Central Statistical Agency, author. CSA. Population and Housing Census Report-Country - 2010, English [eng] Addis Ababa, Ethiopia and Calverton, Maryland, USA: Central Statistical Agency and ICF International; 2010. Ethiopia [eth] Publisher(s): Central Statistical Agency, Addis Ababa, Ethiopia. [Google Scholar]
  • 34.Ethiopian Federal Minster of Health, author. Health and Health Related Indicators, Addis Ababa, Ethiopia. Addis Ababa, Ethiopia: 2012. pp. 29–42. [Google Scholar]
  • 35.Ethiopian Federal Minster of Health, author. Guidelines for Clinical and Programmatic Management of TB, TB/HIV and Leprosy in Ethiopia. 2013. pp. 9–154. [Google Scholar]
  • 36.WHO, Department of Immunization V and B, author. Training for mid-level managers (MLM): 7. The EPI coverage survey. Geneva, Switzerland: 2008. [Google Scholar]
  • 37.Kessler R, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand S-TL, et al. Short screening scales to monitor population prevalence and trends in nonspecific psychological distress. Psychol Med. 2002;32:959. doi: 10.1017/s0033291702006074. [DOI] [PubMed] [Google Scholar]
  • 38.Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184. doi: 10.1001/archpsyc.60.2.184. [DOI] [PubMed] [Google Scholar]
  • 39.Peltzer K, Naidoo P, Matseke G, Louw J, Mchunu G, Tutshana B. Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa. BMC Psychiatry. 2012;12:89. doi: 10.1186/1471-244X-12-89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Deribew A, Tesfaye M, Hailmichael Y, Apers L, Abebe G, Duchateau L, et al. Common mental disorders in TB/HIV co-infected patients in Ethiopia. BMC Infect Dis. 2010;10:201. doi: 10.1186/1471-2334-10-201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Saunders JB, Aasland OG, Amundsen A, Grant M. Alcohol consumption and related problems among primary health care patients: WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction. 1993;88(3):349–362. doi: 10.1111/j.1360-0443.1993.tb00822.x. [DOI] [PubMed] [Google Scholar]
  • 42.Government of Western Australian Department of Health, author. Mental Health Smoking Assessment Check list. 2013. HP012591 JAN'13. [Google Scholar]
  • 43.Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JDH. The Social Determinants of Tuberculosis: From Evidence to Action, Framing Health Matters. Am J Public Heal. 2011;101(4):654–662. doi: 10.2105/AJPH.2010.199505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Prince M, Patel V, Saxena S, Maj M, Maselko J, Philips MR. No health without mental health. Lancet. 2007;370(9590):859–877. doi: 10.1016/S0140-6736(07)61238-0. [DOI] [PubMed] [Google Scholar]

Articles from Ethiopian Journal of Health Sciences are provided here courtesy of College of Public Health and Medical Sciences of Jimma University

RESOURCES